Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Roy Vagelos Net Worth & Insider Trades

Roy Vagelos - Director, Theravance Inc

As of December 23, 2009

What is Roy Vagelos's Net Worth?

The current estimated net worth of Theravance Inc's Director, Roy Vagelos, is estimated to be about $497.79M . Roy Vagelos owns about 513,006 units of Theravance Inc common stock. In the last 3 years at Theravance Inc, Roy Vagelos has sold an estimated value of $0 worth.

What is Roy Vagelos's Past Insider Trading?

Roy Vagelos's largest purchase order was 31,700 units , worth over $331.34K on March 17, 2008. In total, Roy Vagelos has made about 7 transactions over 3 years of their time at Theravance Inc. Roy Vagelos usually trades in April, with the busiest year in 2008. The most recent transaction was a purchase order of 17,300 units , worth over $177.36K on March 17, 2008.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ROY VAGELOS

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Theravance Inc's Past Insider Trades?

Theravance Inc's most recent insider trade came on July 19, 2023 by Carl Gordon who bought 479,932 units worth $1.46M . In the last 19 years, insiders at Theravance Inc have sold an estimated value of $79.05M and bought an estimated value of $613.73M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Michael W Aguiar, President & CEO,  Bradford J Shafer, Sr VP,  and Mathai Mammen, SVP .

Theseus Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...